Rvnc investor alert: kirby mcinerney llp reminds revance therapeutics, inc. investors of looming lead plaintiff deadline in class action lawsuit

New york, feb. 20, 2025 (globe newswire) -- the law firm of kirby mcinerney llp notifies investors of the approaching march 4, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired revance therapeutics, inc. (“revance” or the “company”) (nasdaq:rvnc) securities between february 29, 2024, through december 6, 2024 (“the class period”).
RVNC Ratings Summary
RVNC Quant Ranking